Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Nepean Hospital, Derby St, Kingswood NSW 2747, Australia

Total all time reports:  1
Latest report: April 27, 2020 12:00 PM
Worker tested positive for COVID-19, Nepean Hospital, Derby St, Kingswood NSW 2747, Australia

Worker tested positive for COVID-19

April 27, 2020 12:00 PM

“A healthcare worker at Nepean hospital in the Blue Mountain region of Sydney has tested positive for COVID-19.

Source: 7news.com.au See Less
Reported By SafelyHQ.com User

Related Reports

July 12, 2020 12:00 PM

“Three Port Authority employees recently tested positive on July 4 and one tested positive on Wednesday for Covid-19. This brings positive cases to the total number of employees to 21.

Source: pittsburgh.cbslocal.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Dairy Queen Grill & Chill, 2719 Charity St, Abbeville, LA 70510, USA

Dairy Queen Grill & Chill, 2719 Charity St, Abbeville, LA 70510, USA

July 12, 2020 12:00 PM

“An Abbeville Dairy Queen employee tests positive for COVID-19. The employee was last at work on July 3.

Source: katc.com See Less
Reported By SafelyHQ.com User

Possible Covid-19 outbreak, Duke's Seafood, 2516 Alki Ave SW, Seattle, WA 98116, USA

Duke's Seafood, 2516 Alki Ave SW, Seattle, WA 98116, USA

July 12, 2020 12:00 PM

“Six more employees at Duke's Seafood in Alki have tested positive for Covid-19 bringing the total to Seven.

Source: westseattleblog.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“An employee at the Willows Bar and Grill on the west side of Coldwater has been diagnosed with COVID-19. The employee las worked shifts on June 24-25 and July 2-3.

Source: wtvbam.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“A line cook at Lucky Pelican restaurant in the Lakewood Ranch area of Sarasota has passed away from Covid-19. His last day at work was Friday July 3.

Source: wfla.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, East 55th on the Lake, 5555 N Marginal Rd, Cleveland, OH 44114, USA

East 55th on the Lake, 5555 N Marginal Rd, Cleveland, OH 44114, USA

July 12, 2020 12:00 PM

“An employee at e55 on the Lake restaurant tested positive for COVID-19. The employee last reported to work on Tuesday, July 7.

Source: fox8.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“Multiple employees at Hops N Drops in El Paso County have tested positive for Covid-19. The restaurant is part of an active outbreak of at least 95 people.

Source: coloradoan.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“Multiple employees at Mezzaluna Aspen in Pitkin County have tested positive for Covid-19. The restaurant is part of an active outbreak of at least 95 people.

Source: coloradoan.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“Multiple employees at the Jack in the Box in Arapahoe County have tested positive for Covid-19. The restaurant is part of an active outbreak of at least 95 people.

Source: coloradoan.com See Less
Reported By SafelyHQ.com User

July 12, 2020 12:00 PM

“A recreations counselor, a junior guards counselor and several other employees at Manasquan Recreation programs have tested positive for the virus

Source: dailyvoice.com See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 8, 2020 12:00 PM

“Company name: Lupin Pharmaceuticals, Inc.
Brand name: Lupin
Product recalled: Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg
Reason of the recall: N-Nitrosodimethylamine (NDMA) Impurity
FDA Recall date: July 08, 2020
Recall details: Lupin Pharmaceuticals Inc. is voluntarily ... See Morerecalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA). Out of an abundance of caution, the company is recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg in the US. To date, Lupin Pharmaceuticals Inc. has not received any reports of adverse events related to this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables.

Metformin Hydrochloride Extended-Release Tablets USP is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg is packaged in 60, 90 and 100 count bottles and was distributed nationwide in the US to wholesalers, distributors, drug chain, mail order pharmacies and supermarkets. The recalled NDC’s are included in the table below:

- Product: Metformin Hydrochloride Extended-Release Tablets USP/ Strength: 500mg/ NDC: 68180-338-01 / Distribution Dates: 11/21/2018 - 05/27/2020

- Product: Metformin Hydrochloride Extended-Release Tablets USP/ Strength: 1000mg/ NDC: 68180-339-09 / Distribution Dates: 11/21/2018 - 05/27/2020

- Product: Metformin Hydrochloride Extended-Release Tablets USP/ Strength: 500mg/ NDC: 68180-336-07 / Distribution Dates: 11/05/2018 - 05/22/2020

- Product: Metformin Hydrochloride Extended-Release Tablets USP/ Strength: 1000mg/ NDC: 68180-337-07 / Distribution Dates: 11/05/2018 - 05/22/2020

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chain, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product NDC’s.

Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 1000mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

May 26, 2020 9:32 AM

“They're trying to kill me serving me raw chicken See Less
Reported By SafelyHQ.com User

April 23, 2020 8:51 AM

“At least 6 employees at this location have tested positive for COVID 19. 5 other area awaiting results. If you were at this location within the last 2 weeks, please call Metro Health to report it. See Less
Reported By SafelyHQ.com User

Glass in food, Serial Grillers (Speedway Blvd.), East Speedway Boulevard, Tucson, AZ, USA

Serial Grillers (Speedway Blvd.), East Speedway Boulevard, Tucson, AZ, USA

March 6, 2020 11:19 PM

“There was glass in my husband's food. Called and reported it and the manager didn't care but acted as if we made it up. See Less
Reported By SafelyHQ.com User

Chicken from Costco is almost raw, Costco Wholesale, 16580 NW 59th Ave, Hialeah, FL 33014, United States

Costco Wholesale, 16580 NW 59th Ave, Hialeah, FL 33014, United States

May 6, 2020 9:35 PM

“Translation:
Honestly, I love Costco, and I'm not trying to put any employee in a bad light, especially in the chicken-rotisserie area. I have a picture of how red hot it is on a piece of ... See Morebtn-link" href="https://safelyhq.com/product/meat#scroll" title="Product: Meat">meat and blood on the bones. Chickens need more fire and cooking.

Original:
Con sinceridad, amo Costco, y no trato de poner en mal a ningun empleado en especial la zona de los asadores de pollo. Tengo la foto lo rojo vivo que esta en una parte de la carne y sangre en los huesos. Los pollos necesitan mas fuego y cocimiento. See Less
Reported By SafelyHQ.com User

May 27, 2020 9:34 AM

“I contacted the manager at your store because my sister consumed an undercooked burger last night and is now very sick. He said that there was no way she can get sick from ... See Mores://safelyhq.com/product/beef#scroll" title="Product: Beef">beef even though a quick google search says otherwise. I’m very disappointed. See Less
Reported By SafelyHQ.com User

June 23, 2020 11:29 AM

“I went to your location, which is 20+ minutes away from my house, I get home and bite into a nugget, and my 10 pack McNuggets all came RAW. Never eating there EVER again. Hoping I don’t get food poison ... See Moreing ☺️ See Less
Reported By SafelyHQ.com User

April 29, 2020 7:00 PM

“Company name: CME America
Brand name: CMEAmerica BodyGuard
Product recalled: Infusion pumps and infusion sets
Reason of the recall: pumps may not deliver fluid at the accuracy specified in the instructions for use and infusion sets may under-deliver fluids
FDA Recall date: April 29, 2020
Recall ... See Moredetails: CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), a leading global medical technology company, today issued the following update regarding two previously announced voluntary recalls, one related to all models of CMEAmerica BodyGuard® infusion pumps (FDA Recall Number: Z-1474-2020) and the other related to one of the device's infusion sets (FDA Recall Number: Z-1442-2020). Both previously announced recalls have now been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means the FDA believes that there is a reasonable probability that use of the recalled product(s) will cause serious adverse health consequences or death.

CME America previously notified customers affected by each recall and provided guidance on the potential impact to device performance when the affected products were used. Today, the company has issued an updated customer letter with additional guidance and to inform customers of the decision to suspend distribution of the BodyGuard® infusion pump system and to remove all existing products from the U.S. market.

The following is a summary of each individual product recall details:

CMEAmerica BodyGuard® Infusion Pump Recall

Details On Jan. 6, 2020, the company initiated a voluntary recall to notify customers of certain scenarios where pumps may not deliver fluid at the accuracy specified in the instructions for use that could result in a slower than expected delivery of medication (under-infusion), and/or faster than expected delivery of medication (over-infusion). Results indicate that pumps may have a delivery inaccuracy of up to ~13%. To date, no reports of patient injury has been received related to this previously announced voluntary recall. CME America has assessed the potential risks associated with the issues outlined in the initial voluntary recall and determined that the BodyGuard® infusion pump may continue to be used in certain situations in accordance with the Operator's Manual and the additional mitigations outlined in the updated customer letter until the pumps have been removed from the market.

To ensure customers retain access to critical medical equipment, particularly as the COVID-19 pandemic continues to evolve in the United States, CME America will implement a phased market removal and will continue to support the following activities in order to help limit clinical disruption and maintain patient focus during the COVID-19 pandemic: Use of products in the field in accordance with the Operator's Manual and the additional mitigations outlined in the updated customer letter; Product service and repair activities at CME America and Authorized Service Depots; and Supply of infusion sets and accessories to support the infusion pumps remaining in the field.

The BodyGuard® infusion pump is designed to deliver fluids or medications into a patient's body in controlled amounts. The pump administers fluids through an infusion tubing set into a patient's vein or through other cleared routes of administration. The system is intended for patients who require maintenance medications, PCA therapy, parenteral nutritional fluids, and general IV fluid therapy in hospital and home care environments. Typical applications for the BodyGuard® infusion pumps include but are not limited to chemotherapy, pain management, TPN, enteral nutrition fluids and antibiotics.

The recall and market removal affect approximately 28,400 devices, including all models of BodyGuard® infusion pumps listed below. These devices are primarily used in outpatient settings.
- BodyGuard 121
- BodyGuard 323
- BodyGuard 545*
- BodyGuard 575*
- BodyGuard 545 ColorVision
- BodyGuard 575 ColorVision
- CMExpress

*Note: These two pump models were inadvertently left out of the initial customer notification

CMEAmerica BodyGuard® Microset Infusion Set Recall

Details On Sept. 16, 2019, the company initiated a voluntary recall to notify customers that certain lots of BodyGuard® Microset infusion sets, when used with the BodyGuard® infusion pump, may under-deliver fluids up to 50% at the highest flow rates. At the time of the recall, CME America informed customers in the recall announcement to discard all remaining inventory of the infusion sets (Catalog #A120-003XYVA) and committed to reimbursing impacted customers. To date, no reports of patient injury has been received related to this previously announced voluntary recall. CME America immediately stopped shipments of the affected infusion sets. This FDA classification does not change the previous guidance provided in the company's September recall announcement to customers. Affected products include:

CMEAmerica BodyGuard® Microset, Catalog #A120-003XYVA.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

May 26, 2020 3:35 AM

“Disgraceful raw chicken was totally all pink from there
what can be done about this? See Less
Reported By SafelyHQ.com User

June 18, 2020 11:00 PM

“Company name: GSK Consumer Healthcare
Brand name: Robitussin
Product recalled: Cough and cold products
Reason of the recall: Incorrect dosing cups
FDA Recall date: June 18, 2020
Recall details: GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Ch ... See Moreildren's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups. During the review of the packaging documents for these products, GSK discovered that the dosing cups for the Children's Robitussin® Honey product are missing the 5 mL and 10 mL graduations, while the dosing cups for the Children's Dimetapp® product are missing the 10 mL graduation. The dosing cups packaged with both products only have the 20 mL graduation.

There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered (as directed in the instructions for use). Children's Robitussin Honey Cough & Chest Congestion DM contains 10 mg dextromethorphan HBr USP and guaifenesin USP 100 mg per 10 mL, and is labeled for children 4 and older, as well as adults. Children's Dimetapp Cold & Cough contains 2 mg brompheniramine maleate USP, 10 mg dextromethorphan HBr USP, and 5 mg phenylephrine HCl USP per 10 mL, and is labeled for children 6 and older, as well as adults.

Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention.

As of the date of the recall announcement, GSK Consumer Healthcare has not received any adverse events related to these products or consumer complaints regarding the incorrect dosing cups supplied with the product. The recall is limited to the three lots listed below:

Children's Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) / 02178 (Exp. Jan. 2022)

Children's Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)

These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately.

Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. In December 2018, GlaxoSmithKline plc reached an agreement with Pfizer, Inc. to combine their consumer health businesses into a new Joint Venture. August 01, 2019 was the first day of the new GSK Consumer Healthcare Joint Venture. Thus, when identifying impacted product, please be aware the Pfizer company name will still be present on the label.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User